Genetic and genomic analyses of Drosophila melanogaster models of chromatin modification disorders
GENETICS · 2023
DOI: 10.1093/genetics/iyad061 ↗Kurz gefasst
Fachartikel in der Zeitschrift GENETICS, 2023. Verfasst von Rebecca A MacPherson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Human Genetics and Department of Genetics and Biochemistry, Clemson University, 114 Gregor Mendel Circle, Greenwood, SC 29646, USA. Hauptthemen laut MEDLINE: Drosophila Proteins, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, NIGMS NIH HHS, NIH.
Abstract (Originalsprache)
Switch/sucrose nonfermentable (SWI/SNF)-related intellectual disability disorders (SSRIDDs) and Cornelia de Lange syndrome are rare syndromic neurodevelopmental disorders with overlapping clinical phenotypes. SSRIDDs are associated with the BAF (Brahma-Related Gene-1 associated factor) complex, whereas CdLS is a disorder of chromatin modification associated with the cohesin complex. Here, we used RNA interference in Drosophila melanogaster to reduce the expression of six genes (brm, osa, Snr1, SMC1, SMC3, vtd) orthologous to human genes associated with SSRIDDs and CdLS. These fly models exhibit changes in sleep, activity, startle behavior (a proxy for sensorimotor integration), and brain morphology. Whole genome RNA sequencing identified 9,657 differentially expressed genes (FDR < 0.05), 156 of which are differentially expressed in both sexes in SSRIDD- and CdLS-specific analyses, including Bap60, which is orthologous to SMARCD1, an SSRIDD-associated BAF component. k-means clustering reveals genes co-regulated within and across SSRIDD and CdLS fly models. RNAi-mediated reduction of expression of six genes co-regulated with focal genes brm, osa, and/or Snr1 recapitulated changes in the behavior of the focal genes. Based on the assumption that fundamental biological processes are evolutionarily conserved, Drosophila models can be used to understand underlying molecular effects of variants in chromatin-modification pathways and may aid in the discovery of drugs that ameliorate deleterious phenotypic effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Human Genetics and Department of Genetics and Biochemistry, Clemson University, 114 Gregor Mendel Circle, Greenwood, SC 29646, USA.
ORCID-Profile: Robert R H Anholt
Förderung
- NICHD NIH HHS
- NIGMS NIH HHS
- NIH
Zitieren
APA
MacPherson, R. A., Shankar, V., Anholt, R. R. H., & Mackay, T. F. C. (2023). Genetic and genomic analyses of Drosophila melanogaster models of chromatin modification disorders. GENETICS. https://doi.org/10.1093/genetics/iyad061
Vancouver
MacPherson RA, Shankar V, Anholt RRH, Mackay TFC. Genetic and genomic analyses of Drosophila melanogaster models of chromatin modification disorders. GENETICS. 2023. doi:10.1093/genetics/iyad061
BibTeX
@article{MacPherson2023,
author = {MacPherson, Rebecca A and Shankar, Vijay and Anholt, Robert R H and Mackay, Trudy F C},
title = {Genetic and genomic analyses of Drosophila melanogaster models of chromatin modification disorders},
journal = {GENETICS},
year = {2023},
doi = {10.1093/genetics/iyad061}
}
EUVIMED